Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 7.1% in December

Alpha Tau Medical Ltd. (NASDAQ:DRTS) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 72,600 shares, a growth of 7.1% from the December 15th total of 67,800 shares. Based on an average daily trading volume, of 45,600 shares, the short-interest ratio is currently 1.6 days. Approximately 0.1% of the company’s shares are sold short.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a “buy” rating and issued a $9.00 target price on shares of Alpha Tau Medical in a research note on Friday, November 22nd.

Alpha Tau Medical Trading Up 0.3 %

Shares of NASDAQ:DRTS traded up $0.01 during midday trading on Monday, hitting $3.91. The company had a trading volume of 92,315 shares, compared to its average volume of 51,170. Alpha Tau Medical has a 12 month low of $1.75 and a 12 month high of $4.08. The stock has a market cap of $273.39 million, a price-to-earnings ratio of -9.09 and a beta of 0.80. The firm has a fifty day simple moving average of $2.99 and a 200 day simple moving average of $2.50.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.